Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs

Cancer Letters(2020)10.1016/j.canlet.2020.05.004Source: DataRank Database

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs is a research paper published in Cancer Letters (2020). On theSindex it has a DataRank of 0. It has been cited 123 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access123 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 5.14)OA: greenTopics (51)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Akhil Srivastava ORCID,Narsireddy Amreddy,Mohammad Razaq,Vipul Pareek ORCID,Rebaz Ahmed

Live enrichment

PubMed:32439419 PMC:PMC7327711 OpenAlex:https://openalex.org/W3024688511

Institut National Du Cancer

Grant: P30CA225520

U.S. Department of Defense

Grant: W81XWH-18-1-0637

U.S. Department of Defense

Grant: W81XWH-19-1-0647

U.S. Department of Defense

Grant: HR18-088

National Institutes of Health

Grant: R01CA233201

National Institutes of Health

Grant: R01 CA167516

National Institute of General Medical Sciences

Grant: P20 GM103639

BLRD VA

Grant: I01 BX003420

National Institutes of Health

Grant: 5R01CA167516-03

HuR Targeted Nanotherapy for Lung Cancer

National Institutes of Health

Grant: 1R01CA233201-01

An improved IL-24 gene-based therapeutic for cancer

National Institutes of Health

Grant: 5P20GM103639-08

Mentoring Translational Cancer Research in Oklahoma

National Institutes of Health

Grant: 3P30CA225520-06S4

Stephenson Cancer Center - Cancer Center Support Grant

U.S. Department of Veterans Affairs

National Cancer Institute

Presbyterian Health Foundation

Oklahoma Center for the Advancement of Science and Technology

FWCI

5.14

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7327711

publisherhttps://api.elsevier.com/content/article/PII:S0304383520302329?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383520302329?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2020.05.004

Fields of Study

Extracellular vesicles in diseaseRNA Interference and Gene DeliveryMicroRNA in disease regulation0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntineoplastic AgentsClinical Trials as TopicDrug Delivery SystemsDrug Resistance, NeoplasmExosomesHumansImmunotherapyNeoplasmsPharmaceutical Vehicles

MeSH Terms

AnimalsAntineoplastic AgentsClinical Trials as TopicHumansImmunotherapyNeoplasmsPharmaceutical VehiclesDrug Delivery SystemsDrug Resistance, NeoplasmExosomes

Keywords

MicrovesiclesDrug resistanceDrugPharmacologyMedicineDrug deliveryBiologyChemistrymicroRNAGeneticsNanocarriersExtracellular VesiclesTangential Flow FiltrationTumor-derived ExosomeTumor-microenvironmentClinical Trials as TopicAntineoplastic AgentsExosomesDrug Delivery SystemsDrug Resistance, NeoplasmNeoplasmsAnimalsHumansImmunotherapyPharmaceutical Vehicles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Enhanced therapeutic effect of PEDF-loaded mesenchymal stem cell-derived small extracellular vesicles against oxygen-induced retinopathy through increased stability and penetrability of PEDF

10.6084/m9.figshare.26616106.v1figshare

10.6084/m9.figshare.26616106figshare

Additional file 2 of Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR

10.6084/m9.figshare.24329926.v1figshare

Additional file 2 of Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR

10.6084/m9.figshare.24329926figshare

Additional file 1 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593529figshare

Additional file 1 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593529.v1figshare

Additional file 3 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593535.v1figshare

Additional file 4 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593538.v1figshare

Additional file 2 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593532.v1figshare

Additional file 2 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593532figshare

Additional file 4 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593538figshare

Additional file 3 of Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

10.6084/m9.figshare.26593535figshare

Additional file 1 of Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR

10.6084/m9.figshare.24329772.v1figshare

Additional file 1 of Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR

10.6084/m9.figshare.24329772figshare

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs

FAIR Checklist

Authors (10)

Funding (16 grants)

Impact

Open Access

Topics

Linked Datasets (14)

Annotations (Europe PMC)